Dysregulation of cholesterol homeostasis is an early signal of β-cell proteotoxicity characteristic of type 2 diabetes.
Saved in:
| Title: | Dysregulation of cholesterol homeostasis is an early signal of β-cell proteotoxicity characteristic of type 2 diabetes. |
|---|---|
| Authors: | Gurlo T; Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States., Liu R; Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, California, United States., Wang Z; Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States., Hoang J; Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States., Ryazantsev S; Electron Imaging Center, California Nano Systems Institute, University of California, Los Angeles, Los Angeles, California, United States., Daval M; Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States., Butler AE; Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States., Yang X; Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, California, United States.; Molecular, Cellular, and Integrative Physiology Interdepartmental Program, University of California, Los Angeles, Los Angeles, California, United States., Blencowe M; Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, California, United States.; Molecular, Cellular, and Integrative Physiology Interdepartmental Program, University of California, Los Angeles, Los Angeles, California, United States., Butler PC; Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States. |
| Source: | Physiological genomics [Physiol Genomics] 2024 Sep 01; Vol. 56 (9), pp. 621-633. Date of Electronic Publication: 2024 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Physiological Society Country of Publication: United States NLM ID: 9815683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-2267 (Electronic) Linking ISSN: 10948341 NLM ISO Abbreviation: Physiol Genomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1531-2267 |
|---|---|
| DOI: | 10.1152/physiolgenomics.00029.2024 |
